Return On Assets of Aspire Biopharma Holdings, Inc. from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aspire Biopharma Holdings, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2022 to 30 Sep 2025.
  • Aspire Biopharma Holdings, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -1492%, a 28727% decline year-over-year.
  • Aspire Biopharma Holdings, Inc. annual Return On Assets for 2024 was -148%, a 3114% decline from 2023.
  • Aspire Biopharma Holdings, Inc. annual Return On Assets for 2023 was 4.9%, a 338% increase from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Aspire Biopharma Holdings, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -1492% -1487% -28727% 01 Jul 2025 30 Sep 2025
Q2 2025 -774% -771% -23545% 01 Apr 2025 30 Jun 2025
Q1 2025 -435% -442% -6548% 01 Jan 2025 31 Mar 2025
Q4 2024 -15% -20% -415% 01 Oct 2024 31 Dec 2024
Q3 2024 -5.2% -9.4% -222% 01 Jul 2024 30 Sep 2024
Q2 2024 -3.3% -6.7% -194% 01 Apr 2024 30 Jun 2024
Q1 2024 6.8% +4.6% +221% 01 Jan 2024 31 Mar 2024
Q4 2023 4.9% +3.8% +338% 01 Oct 2023 31 Dec 2023
Q3 2023 4.2% +3.8% +755% 01 Jul 2023 30 Sep 2023
Q2 2023 3.5% 01 Apr 2023 30 Jun 2023
Q1 2023 2.1% 01 Jan 2023 31 Mar 2023
Q4 2022 1.1% 01 Oct 2022 31 Dec 2022
Q3 2022 0.5% 01 Jul 2022 30 Sep 2022

Aspire Biopharma Holdings, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -148% -153% -3114% 01 Jan 2024 31 Dec 2024
2023 4.9% +3.8% +338% 01 Jan 2023 31 Dec 2023
2022 1.1% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.